Innoser Menu
Accessibility
As of 1 January 2019 we will no longer be accessible by phone via our Dutch number. You can reach us via 32 (0) 11 28 69 00 or info@innoserlaboratories.com.
News

News

Leap into the future; Development of a PDXO drug screening platform

Diepenbeek, December 10th 2018 – BioVille-InnoSer NV, a young and innovative Belgium based Contract Research Organization (CRO) has received an over € 1.6 million grant from the Flemish VLAIO. This development grant is awarded to set up a PDXO screening platform in partnership with Trace/KU Leuven and in close collaboration with Jessa Hospital, Hasselt (B) and Leiden University Medical Center (LUMC) in the Netherlands. Read more >>

InnoSer joins TRANSMED programme

TRANSMED brings together four academic groups with four non-academic and SME partners and four associated partners. The academic groups are EKUT, UNIMORE, ULUND and HI, the non-academic and SME partners are SPPD, INCU, Oculis and InnoSer. The four associated partners are 2BBB, BIOLOG, NLO and HCTC. Read more >>

Pkd: a unique in vivo mouse assay

At InnoSer we deliver an in vivo mouse assay facilitating drug discovery for Autosomal Dominant Polycystic Kidney Disease (ADPKD). ADPKD is a genetic kidney disease, with a prevalence of 4 to 10.000. Read more >>

Job opportunities at InnoSer

Currently there are two job opportunities at InnoSer. As a Contract Research Organisation (CRO) acting in the preclinical phase in several therapeutic fields, we offer highly sophisticated transgenic services. Due to the expansion of our activities into Belgium and to accelerate growth, we are looking for (commercial) talent to strengthen our young team and broaden our network. Read more >>

InnoSer expands its operation to Belgium

From December 1st onwards InnoSer will be operational in Belgium. By its presence, we want to accommodate the increasing demand for preclinical research expertise and infrastructure in Belgium as well as strengthening our position on the European market. Read more >>

Ellen Boelen InnoSer’s new Business Development Manager

Ellen Boelen joined the InnoSer team as its new Business Development Manager recently. “It is great to be part of this innovating company, bringing me in such an challenging environment. Read more >>

Leiden facility: AAALAC International accreditation

InnoSer proudly announces that its preclinical service facility in Leiden, The Netherlands has been granted full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. Read more >>

Innoser expands its operations to Belgium

InnoSer expands its activities to Belgium by opening a new facility in BioVille, a bio-incubator located at the university campus in Diepenbeek. By its presence, InnoSer wants to accommodate the increasing demand for preclinical research expertise and infrastructure in Belgium as well as strengthening its position on the European market. InnoSer’s establishment in Belgium could be accomplished by the facility support of LRM, Limburg’s investment company. Read more >>
The Netherlands – December 17, 2014

TNO companies and InnoSer announced collaboration

TNO companies and InnoSer announced a collaboration in facilitating biomedical research in Leiden, involving GA in vivo models, pre-clinical studies and contract research activities. Read more >>
The Netherlands – November 2014

ISO 9001:2008 certification

Being an innovative service solution company in the biomedical industry, InnoSer has incorporated the internationally recognized ISO 9001:2008 quality management standards into their work processes. We have successfully completed the stages of implementation, analysis and evaluation. Read more >>

Home